PHARMA-SKAN ApS: Financial statements 2014
CVR: 16275247
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
PHARMA-SKAN ApS (CVR 16275247) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 11,464,201 and a net result of DKK 8,316,065 compared with DKK 8,200,105 the year before. That is an increase of 0.9% compared with the year before. Equity in the 2014 report amounted to DKK 14,119,222. The solvency ratio was 35.2%. The company had 8 employees in the financial year.
- Gross Profit
- DKK 11,464,201
- Profit/Loss
- DKK 8,316,065
- Equity
- DKK 14,119,222
- Total Assets
- DKK 40,107,632
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 11.5 mio. | 8.3 mio. | 14.1 mio. | 8 |
| 2013 | - | 11.4 mio. | 8.2 mio. | 15.8 mio. | 9 |
| 2012 | - | 11.6 mio. | 8.4 mio. | 17.6 mio. | 10 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
PHARMA-SKAN ApS has published its annual report for 2013. Gross profit came to DKK 11,364,792, and the net result was DKK 8,200,105.
About PHARMA-SKAN ApS
PHARMA-SKAN ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS KBUS 38 NR. 2587. The management consists of Line Wulff and Ib Gunnar Christensen. The board consists of Jan Dam (chair), Kent Ernst Hansen, Lars Enghave Minor and Line Wulff. The company is owned by BESULA ApS. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK 12,339,941 and a net result of DKK 7,875,190 compared with DKK 11,288,304 the year before. Equity in the 2025 report amounted to DKK 8,543,005.